Literature DB >> 22205508

Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23.

Ryo Narazaki1, Kenji Ihara, Noriyuki Namba, Hiroshi Matsuzaki, Keiichi Ozono, Toshiro Hara.   

Abstract

BACKGROUND: Linear nevus sebaceous syndrome (LNSS) is a rare congenital neuroectodermal disorder characterized by involvement of the skeleton and central nervous system. CASE: We report the case of a 5-year-old girl who had LNSS with hypophosphatemic rickets and multiple fractures of her extremities. Biochemical tests revealed a high serum level of fibroblast growth factor-23 (FGF-23) but normal levels of immunoglobulin E (IgE) and parathormone (PTH). FGF-23 mRNA expression in the skin lesions of our patient's skin was found to be below the limit of detection in all samples tested by quantitative-PCR analysis.
CONCLUSIONS: It is possible that an as-yet unidentified substance increases FGF-23 expression LNS lesions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22205508     DOI: 10.1007/s00467-011-2086-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Linear sebaceous naevus syndrome and resistant rickets.

Authors:  B Guhan; R D D Duncan
Journal:  J Bone Joint Surg Br       Date:  2004-01

2.  Hypophosphatemic rickets associated with epidermal nevus syndrome and giant hairy nevus.

Authors:  Yen-Yin Chou; Sheau-Chiou Chao; Chiou-Nan Shiue; Wen-Hui Tsai; Shio-Jean Lin
Journal:  J Pediatr Endocrinol Metab       Date:  2005-01       Impact factor: 1.634

3.  Congenital linear sebaceous nevus syndrome.

Authors:  G L Klein; J S Dallas; H K Hawkins; L E Swischuk; R L McCauley
Journal:  J Bone Miner Res       Date:  1998-06       Impact factor: 6.741

4.  Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

Authors:  Yuji Yamazaki; Ryo Okazaki; Minako Shibata; Yukihiro Hasegawa; Kohei Satoh; Toshihiro Tajima; Yasuhiro Takeuchi; Toshiro Fujita; Kazuhiko Nakahara; Takeyoshi Yamashita; Seiji Fukumoto
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

5.  Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.

Authors:  D E Carey; M K Drezner; J A Hamdan; M Mange; M S Ahmad; S Mubarak; W L Nyhan
Journal:  J Pediatr       Date:  1986-12       Impact factor: 4.406

6.  Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats.

Authors:  Iddo Z Ben-Dov; Orit Pappo; Miri Sklair-Levy; Hillel Galitzer; Yaron Ilan; Tally Naveh-Many; Justin Silver
Journal:  Nephrol Dial Transplant       Date:  2006-11-07       Impact factor: 5.992

7.  Elevated fibroblast growth factor-23 in hypophosphatemic linear nevus sebaceous syndrome.

Authors:  William H Hoffman; Harald W Jueppner; Barry R Deyoung; M Sue O'dorisio; Keena S Given
Journal:  Am J Med Genet A       Date:  2005-04-30       Impact factor: 2.802

8.  Schimmelpenning-Feuerstein-Mims syndrome with hypophosphatemic rickets.

Authors:  M Zutt; F Strutz; R Happle; E M Habenicht; St Emmert; H A Haenssle; L Kretschmer; Ch Neumann
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

9.  Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions.

Authors:  L C Aschinberg; L M Solomon; P M Zeis; P Justice; I M Rosenthal
Journal:  J Pediatr       Date:  1977-07       Impact factor: 4.406

10.  Regulation of fibroblast growth factor-23 in chronic kidney disease.

Authors:  Per-Anton Westerberg; Torbjörn Linde; Björn Wikström; Osten Ljunggren; Mats Stridsberg; Tobias E Larsson
Journal:  Nephrol Dial Transplant       Date:  2007-06-13       Impact factor: 5.992

View more
  6 in total

Review 1.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 2.  Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment.

Authors:  D Ovejero; Y H Lim; A M Boyce; R I Gafni; E McCarthy; T A Nguyen; L F Eichenfield; C M C DeKlotz; L C Guthrie; L L Tosi; P S Thornton; K A Choate; M T Collins
Journal:  Osteoporos Int       Date:  2016-08-06       Impact factor: 4.507

3.  Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia.

Authors:  Young H Lim; Diana Ovejero; Jeffrey S Sugarman; Cynthia M C Deklotz; Ann Maruri; Lawrence F Eichenfield; Patrick K Kelley; Harald Jüppner; Michael Gottschalk; Cynthia J Tifft; Rachel I Gafni; Alison M Boyce; Edward W Cowen; Nisan Bhattacharyya; Lori C Guthrie; William A Gahl; Gretchen Golas; Erin C Loring; John D Overton; Shrikant M Mane; Richard P Lifton; Moise L Levy; Michael T Collins; Keith A Choate
Journal:  Hum Mol Genet       Date:  2013-09-04       Impact factor: 6.150

Review 4.  Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy.

Authors:  Young H Lim; Diana Ovejero; Kristina M Derrick; Michael T Collins; Keith A Choate
Journal:  J Am Acad Dermatol       Date:  2016-08       Impact factor: 11.527

Review 5.  Hypophosphatemic rickets due to perturbations in renal tubular function.

Authors:  Maria Goretti M G Penido; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2013-05-01       Impact factor: 3.714

6.  Usefulness of 68Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia.

Authors:  Dong Yun Lee; Seung Hun Lee; Beom-Jun Kim; Wanlim Kim; Pil Whan Yoon; Sang Ju Lee; Seung Jun Oh; Jung-Min Koh; Jin-Sook Ryu
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.